How Much Did Koniku Raise?
Funding & Key Investors

Koniku has solidified its position at the intersection of synthetic neurobiology and silicon engineering, securing a total capital infusion of $1.6M. This latest financial milestone, characterized by a $0 injection, underscores the firm's transition into a critical player within the deep-tech sector. By successfully bridging the gap between biological neural networks and traditional computing architectures, the company continues to attract significant interest from institutional backers focused on high-barrier-to-entry technological advancements.

What is Koniku?

Koniku
Business ServicesResearch & Development

Koniku operates as a pioneering neurotechnology enterprise, distinguished by its development of co-processors that utilize biological neurons integrated with silicon. This unique approach enables the creation of highly sensitive detection systems capable of identifying specific particles with unprecedented accuracy. The company's market strategy targets high-stakes environments, including global airport security, defense-grade military applications, and precision agriculture. By replacing traditional chemical sensors with bio-inspired hardware, Koniku provides a scalable solution for organizations requiring real-time, reliable quality assurance and threat detection capabilities in complex operational landscapes.

How much funding has Koniku raised?

Koniku has raised a total of $1.6M across 2 funding rounds:

2016

Private Equity

$1.4M

2020

Debt

$150K

Private Equity (2016): $1.4M, investors not publicly disclosed

Debt (2020): $150K led by PPP

Key Investors in Koniku

Undisclosed Investor

A private equity firm focused on long-term capital appreciation and strategic growth in deep-tech and emerging hardware sectors.

PPP

Public-Private Partnership

Strategic Partner

An undisclosed entity specializing in early-stage and growth-stage investments within the biotech and neurotechnology ecosystem.

What's next for Koniku?

With the recent influx of capital, Koniku is positioned to accelerate the commercial deployment of its proprietary neuro-silicon platforms. The strategic roadmap likely involves scaling manufacturing processes to meet the rigorous demands of enterprise-level clients in the security and agricultural sectors. As the company moves beyond the development phase, the focus will shift toward establishing long-term service contracts and expanding the versatility of its biological sensors. Investors are closely monitoring the firm's ability to maintain its technological lead while navigating the regulatory and ethical frameworks inherent in synthetic biology, ensuring that their bio-inspired detection systems become the industry standard for next-generation sensing technology.

See full Koniku company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesProject Management
Business ServicesProject Management
Business ServicesResearch & Development
Business ServicesGraphicsArchitecture, Engineering & DesignConstruction

Frequently Asked Questions Regarding Koniku Financial Insights

What are the most recent funding rounds that Koniku has completed, and what were the funding rounds?
Koniku has recently completed 2 funding rounds: Debt on Apr 30, 2020, Private Equity on Aug 1, 2016.
What is the total amount of funding Koniku has raised to date?
Koniku has raised a total of $1.6M in funding to date.
How many funding rounds has Koniku completed?
Koniku has completed 2 funding rounds.
How much funding did Koniku raise in its most recent funding round?
Koniku raised $150K in its most recent funding round.
Who are the lead investors in Koniku's latest funding round?
The lead investor in Koniku's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Koniku's history?
The largest funding round in Koniku's history was $1.4M.
See more information about Koniku